The global medical devices reimbursement market size was valued at USD 611.09 billion in 2025 and is projected to grow from USD 675.87 billion in 2026 to USD 1513.22 billion by 2034, registering a CAGR of 10.6% during the forecast period from 2026 to 2034. North America dominated the medical devices reimbursement market with a market share of 42.6% in 2025.
Medical devices reimbursement refers to the payment made by public or private healthcare payers to providers for covered medical devices and related procedures. It generally involves three key elements: coverage, coding, and payment. Reimbursement depends on the payer, device, healthcare setting, clinical evidence, and applicable payment policies.
Download a Free Sample To learn more about this report,
Faster Alignment Between Device Approval and Medicare Coverage
The medical devices reimbursement market is increasingly moving toward faster and more predictable coverage pathways for innovative technologies. Payers and regulators are placing greater emphasis on clinical evidence, medical necessity, cost effectiveness, and timely patient access. In the US, Medicare payment methodologies continue to vary by healthcare setting, while new technologies may qualify for specific temporary or alternative payment mechanisms.
Growing Focus on Value-Based and Cost-Efficient Reimbursement
Another important medical devices reimbursement market trend is the increasing focus on payment accuracy, cost containment, and value-based healthcare. Payers are increasingly evaluating whether medical technologies demonstrate measurable clinical value while controlling healthcare expenditure. CMS has also continued developing payment approaches that use market-based pricing and competitive bidding to improve payment accuracy.
Growing Demand for Advanced Medical Devices and Healthcare Services
The increasing adoption of advanced medical devices for diagnosis, treatment, monitoring, and chronic disease management is driving the medical devices reimbursement market. Rising healthcare utilization and the growing need for technologically advanced treatments are encouraging payers to develop reimbursement mechanisms that support access to innovative devices. Different healthcare settings also use different Medicare payment methodologies, creating continued demand for structured reimbursement pathways.
Complex Coverage and Reimbursement Requirements
Complex coding, coverage, documentation, and payment requirements can limit reimbursement for medical devices. Manufacturers must demonstrate that products meet applicable coverage criteria and provide sufficient clinical evidence, while healthcare providers must follow payer-specific billing and documentation requirements. These processes can increase administrative costs and delay market access.
Faster Reimbursement Pathways for Innovative Technologies
The development of coordinated coverage pathways is creating opportunities for manufacturers of innovative medical devices. Earlier engagement between regulators, manufacturers, and payers can help companies generate clinical evidence that supports both regulatory approval and reimbursement decisions. This can reduce uncertainty and improve access to emerging technologies.
Balancing Cost Control with Patient Access to Innovation
Payers face the challenge of controlling healthcare expenditure while ensuring patients can access effective and innovative medical technologies. Reimbursement decisions increasingly require evidence of clinical benefit, medical necessity, and appropriate utilization. Differences in payment methodologies across hospitals, outpatient facilities, and other settings can further complicate reimbursement planning.
Public Segment Dominated the Market with 61.8% Share in 2025
The public segment dominated the medical devices reimbursement market with a 61.8% share in 2025, reaching USD 377.65 billion, and is projected to grow at a CAGR of 8.03% during 2026–2034. The private segment accounted for a 38.2% share, reaching USD 233.44 billion, and is projected to grow at a CAGR of 9.02%.
Public reimbursement remains dominant because government-funded healthcare programs cover a large share of medical procedures and device-related treatments. Private payers are also gaining importance as demand for specialized treatments, advanced medical technologies, and broader healthcare coverage increases.
Request Customizationto receive a tailored report.
Outpatient Facilities Segment is Projected to Grow at a CAGR of 9.07%
The outpatient facilities segment accounted for a 31.6% share of the medical devices reimbursement market in 2025, reaching USD 193.10 billion, and is projected to grow at a CAGR of 9.07% during 2026–2034. Hospitals accounted for a 58.4% share, reaching USD 356.88 billion, while other healthcare settings represented 10%, reaching USD 61.11 billion.
The shift toward outpatient care is increasing as healthcare providers seek more convenient, cost-efficient treatment models. Hospitals remain the largest setting because complex procedures and advanced medical devices continue to require specialized infrastructure, while outpatient facilities are increasingly used for less complex procedures, diagnostics, and device-supported treatments.
Speak to an Analystto discuss market opportunities.
North America dominated the medical devices reimbursement market with a 42.6% share in 2025, reaching USD 260.32 billion, and is projected to grow at a CAGR of 8.12% during 2026–2034. The region's leading position is supported by advanced healthcare infrastructure, extensive public and private insurance coverage, high healthcare expenditure, and strong adoption of innovative medical devices. Established reimbursement systems and growing demand for specialized treatments are also supporting regional market growth.
The US market is supported by extensive public and private healthcare coverage, high medical spending, and widespread adoption of advanced medical devices. Medicare, Medicaid, and private insurers play an important role in supporting reimbursement, while increasing demand for innovative treatments and outpatient care is contributing to market growth.
Canada's market is supported by its publicly funded healthcare system, increasing healthcare expenditure, and growing adoption of advanced medical technologies. Rising demand for diagnostic, therapeutic, and implantable devices is supporting reimbursement activity across healthcare settings.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 29.4% of the medical devices reimbursement market in 2025, reaching USD 179.66 billion, and is projected to grow at the fastest CAGR of 9.36% during 2026–2034. Growth is supported by established healthcare systems, government-funded healthcare programs, increasing adoption of innovative medical technologies, and rising demand for specialized treatments. Healthcare modernization and growing emphasis on cost-effective care are also supporting regional expansion.
Germany's market benefits from a well-established healthcare and insurance system, high healthcare expenditure, and strong adoption of advanced medical devices. Increasing demand for cardiovascular, orthopedic, diagnostic, and other specialized technologies is supporting reimbursement growth.
The UK market is supported by the National Health Service, increasing adoption of medical technologies, and growing demand for specialized and cost-effective treatments. Greater use of outpatient services and continued healthcare modernization are also contributing to reimbursement market development.
Asia Pacific accounted for 18.7% of the medical devices reimbursement market in 2025, reaching USD 114.27 billion, and is projected to grow at a CAGR of 8.84% during 2026–2034. Growth is supported by expanding healthcare infrastructure, rising healthcare expenditure, increasing insurance coverage, and growing adoption of advanced medical devices. Improvements in healthcare access and the expansion of private healthcare services are also supporting regional growth.
Japan's market is supported by its advanced universal healthcare system, aging population, and high adoption of medical technologies. Increasing demand for cardiovascular, orthopedic, diagnostic, and chronic disease management devices is contributing to reimbursement activity.
China's market benefits from expanding healthcare infrastructure, increasing health insurance coverage, and rising healthcare expenditure. Growing demand for advanced medical devices and improvements in healthcare access are supporting the expansion of reimbursement services.
Middle East and Africa accounted for 4% of the medical devices reimbursement market in 2025, reaching USD 24.44 billion, and is projected to grow at a CAGR of 6.91% during 2026–2034. Growth is supported by healthcare infrastructure investments, insurance expansion, increasing adoption of advanced medical technologies, and healthcare system modernization. Rising demand for specialized medical treatment is also supporting reimbursement market development.
The UAE market is supported by investments in advanced healthcare infrastructure, expanding health insurance coverage, and increasing adoption of innovative medical technologies. Growing demand for specialized treatments and private healthcare services is contributing to reimbursement market growth.
Africa's market is supported by gradual expansion of healthcare infrastructure, increasing healthcare investment, and efforts to improve access to medical services. Growing insurance coverage and adoption of essential and advanced medical devices are creating opportunities for reimbursement market development.
The medical devices reimbursement market is competitive, with major healthcare insurers and financial service providers focusing on reimbursement management, claims processing, cost control, value-based care, and digital healthcare solutions. Key players include UnitedHealth Group, Aetna, Cigna, Humana, Allianz, Aviva, CVS Health, WellCare Health Plans, and BNP Paribas. Competition is increasingly shaped by the use of digital claims platforms, prior-authorization management, data analytics, and value-based reimbursement models. Payers are also working to improve payment transparency and streamline reimbursement processes across hospitals and outpatient healthcare settings. UnitedHealthcare, for example, regularly updates reimbursement policies covering devices, implants, and other healthcare services.
UnitedHealth Group
UnitedHealth Group maintains a strong position through its UnitedHealthcare insurance business and Optum healthcare services. The company focuses on integrated healthcare delivery, claims management, value-based care, and digital reimbursement solutions. Its Optum business is also investing in technology to simplify claims and reimbursement processes and improve payment transparency.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
Facial Fat Transfer Market Size, Share, Growth, Analysis, 2034
Viral Vector Manufacturing Market Size, Share, Growth, Analysis, 2034
Medical Equipment Rental Market Size, Share, Growth, 2034
Pharmaceutical Stability and Storage Services Market Size, 2034
We are featured on:
sales@straitsresearch.com